Fosamax Multidistrict Litigation

Document Sample
Fosamax Multidistrict Litigation Powered By Docstoc
					              Fosamax Multidistrict Litigation
Fosamax Manufacturers face Multidistrict Litigation.

( Dec 15, 2011 -- Bisphosphonates drugs like Fosamax are proven effective to treat
and prevent osteoporosis but recent published reports indicated that there is an increasing
number of lawsuits being filed in the basis of the adverse side effects of the drug. These adverse
side effects of Fosamax prod patients to take legal action.

Below is an excerpt from a trusted website regarding Fosamax Multidistrict Litigation.

A multidistrict litigation (MDL) was made to cater all these lawsuits as mandated by the New
York Court. It was on 2006 that this MDL happened. As for update, A Fosamax MDL court
decision has been issued.

The results from this Fosamax MDL have brought excitement to many people. But the outcome
turned out to be quite depressing for plaintiffs. These lawsuits came about after the drug received
complaints from its users. Manufacturers also failed to provide information about the possible
occurrence of femur fractures was also one of the complaints. The Supreme Court believes that a
generic Fosamax manufacturer cannot be expected to provide a warning when the brand name
manufacturers cannot even do it.

It is said that this MDL decision is a big factor in terms of people pursuing compensation from a
generic manufacturer of Fosamax.

Read more about Fosamax Multidistrict Litigation here.


Shared By: